BRIEF published on 10/11/2024 at 07:35, 1 year 10 months ago Poxel publie son document d'enregistrement universel 2023 Gouvernance D'Entreprise Rapport Financier Annuel Poxel Rapport RSE Document D'enregistrement 2023
PRESS RELEASE published on 10/11/2024 at 07:30, 1 year 10 months ago Annual financial and audit reports / Terms of availability of the annual financial report Poxel announces availability of the 2023 Universal Registration Document including financial and governance reports, now filed with the AMF AMF Biopharmaceutical Company Financial Report Universal Registration Document Poxel
PRESS RELEASE published on 10/11/2024 at 07:30, 1 year 10 months ago Rapports financiers et d'audit annuels / Modalités de mise à disposition du rapport financier annuel Poxel annonce la mise à disposition de son Document d'Enregistrement Universel 2023 auprès de l'AMF pour l'exercice clos au 31 décembre 2023, incluant rapports financiers et sociaux AMF Maladies Métaboliques Document D'Enregistrement Universel Traitements Innovants Poxel
BRIEF published on 10/03/2024 at 18:35, 1 year 11 months ago Poxel annonce ses résultats financiers et stratégiques pour 2023 Résultats Financiers Biopharmaceutique TWYMEEG® Poxel OrbiMed
BRIEF published on 10/03/2024 at 18:35, 1 year 11 months ago Poxel announces its financial and strategic results for 2023 Financial Results Biopharmaceutical TWYMEEG® Poxel OrbiMed
PRESS RELEASE published on 10/03/2024 at 18:30, 1 year 11 months ago Informations privilégiées / Communiqué sur comptes, résultats Poxel publie ses résultats financiers pour l'année 2023 et dresse un bilan de ses activités. Accord avec OrbiMed, webinaires de présentation et perspectives de croissance Résultats Financiers Croissance Webinaires Poxel OrbiMed
BRIEF published on 09/30/2024 at 07:35, 1 year 11 months ago Poxel Secures $50M Non-Dilutive Financing from OrbiMed Non-dilutive Financing TWYMEEG® Poxel Royalty Monetization OrbiMed
BRIEF published on 09/30/2024 at 07:35, 1 year 11 months ago Poxel obtient un financement non dilutif de 50 millions de dollars auprès d'OrbiMed Financement Non Dilutif TWYMEEG® Poxel Monétisation Des Redevances OrbiMed
PRESS RELEASE published on 09/30/2024 at 07:30, 1 year 11 months ago Inside Information / Other news releases Poxel monetizes TWYMEEG® royalties in a USD 50 million deal with OrbiMed. Proceeds to reduce debt and support rare disease activities. Webinars scheduled for investor updates Webinars Royalties TWYMEEG® Poxel OrbiMed
BRIEF published on 09/09/2024 at 07:35, 1 year 11 months ago POXEL annonce une hausse significative de ses ventes au deuxième trimestre 2024 Partenariats Trésorerie Ventes TWYMEEG® Poxel
Published on 09/05/2026 at 04:05, 2 days 4 hours ago Pelican AI Corp. Announces Proposed Share Issuances and Litigation Update
Published on 09/04/2026 at 23:30, 2 days 8 hours ago FutureGen Industries Announces Shares for Debt Settlement
Published on 09/04/2026 at 23:00, 2 days 9 hours ago Golden Minerals Announces Management Change and Argentine Project Update
Published on 09/04/2026 at 22:30, 2 days 9 hours ago Panther Minerals Closes Brokered Private Placement of $3,000,000
Published on 09/04/2026 at 14:30, 2 days 17 hours ago Additional Infant Patient to Receive Jaguar Health's Crofelemer for Compassionate Use for Treatment of Intestinal Failure (IF)
Published on 09/07/2026 at 08:00, 16 minutes ago £175m first close of Molten Ventures Growth Fund with cornerstone commitment from British Business Bank
Published on 09/07/2026 at 07:30, 46 minutes ago Hannover Re sees profitable growth opportunities in an increasingly challenging market environment
Published on 09/07/2026 at 07:00, 1 hour 16 minutes ago Swiss Re sees growing protection needs as risks become more complex and interconnected
Published on 09/07/2026 at 07:00, 1 hour 16 minutes ago Half-year results for 2026 show a further increase
Published on 09/04/2026 at 18:57, 2 days 13 hours ago Disclosure of transactions in own shares from September 1 to September 4, 2026
Published on 09/04/2026 at 18:57, 2 days 13 hours ago Déclaration hebdomadaire d'opérations effectuées du 1er au 4 septembre 2026
Published on 09/04/2026 at 18:15, 2 days 14 hours ago ALTAREIT : INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
Published on 09/04/2026 at 18:15, 2 days 14 hours ago ALTAREA : INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
Published on 09/04/2026 at 18:15, 2 days 14 hours ago ALTAREIT : DÉCLARATION MENSUELLE DES OPÉRATIONS RÉALISÉES PAR LA SOCIÉTÉ SUR SES PROPRES TITRES AOÛT 2026
